This sample article is repository-managed content for initial launch. It is intentionally careful: proposed applications may support research and development decisions but remain subject to validation, partner review, and applicable regulatory requirements.

Key considerations

Multimodal oncology programs should begin with clinically important questions, define partner and data-use rights clearly, and validate before scaling toward product workflows.